Premenstrual multiple sclerosis pseudoexacerbations: Role of body temperature and prevention with aspirin

Dean Marko Wingerchuk, Moses Rodriguez

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background: Many women with multiple sclerosis (MS) experience transient neurologic symptom worsening and fatigue in conjunction with the menstrual cycle. Aspirin reduces MS fatigue in some patients. Objective: To describe 3 women with MS who experienced stereotypic, temperature-independent neurologic symptoms and diurnal fatigue in the mid-to-late luteal phase of the menstrual cycle. Aspirin treatment prevented the symptoms. Design and Setting: Case series at the Mayo Clinic outpatient MS clinics, Scottsdale, Ariz, and Rochester, Minn. Patients: Three women with relapsing-remitting MS. Interventions: Body temperature measurement, symptom diary, and oral aspirin. Main Outcome Measures: Body temperature, Modified Fatigue Impact Scale, and evaluation of neurologic symptoms and signs. Results: Morning oral body temperature did not differ during symptomatic vs asymptomatic portions of the luteal phase (P= .55). Aspirin (650 mg twice daily) prevented symptoms but did not significantly alter the luteal phase body temperature. Conclusions: Aspirin prophylaxis may prevent luteal phase-associated MS pseudoexacerbations. However, the observed relationship between the luteal menstrual phase and MS symptom worsening is not fully explained by thermoregulation, which implicates other hormonal or immunologic mechanisms.

Original languageEnglish (US)
Pages (from-to)1005-1008
Number of pages4
JournalArchives of Neurology
Volume63
Issue number7
DOIs
StatePublished - 2006

Fingerprint

Body Temperature
Luteal Phase
Aspirin
Multiple Sclerosis
Fatigue
Neurologic Manifestations
Relapsing-Remitting Multiple Sclerosis
Body Temperature Regulation
Menstrual Cycle
Ambulatory Care Facilities
Temperature
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Premenstrual multiple sclerosis pseudoexacerbations : Role of body temperature and prevention with aspirin. / Wingerchuk, Dean Marko; Rodriguez, Moses.

In: Archives of Neurology, Vol. 63, No. 7, 2006, p. 1005-1008.

Research output: Contribution to journalArticle

@article{eb95de6411ae4235a730c64a485e0642,
title = "Premenstrual multiple sclerosis pseudoexacerbations: Role of body temperature and prevention with aspirin",
abstract = "Background: Many women with multiple sclerosis (MS) experience transient neurologic symptom worsening and fatigue in conjunction with the menstrual cycle. Aspirin reduces MS fatigue in some patients. Objective: To describe 3 women with MS who experienced stereotypic, temperature-independent neurologic symptoms and diurnal fatigue in the mid-to-late luteal phase of the menstrual cycle. Aspirin treatment prevented the symptoms. Design and Setting: Case series at the Mayo Clinic outpatient MS clinics, Scottsdale, Ariz, and Rochester, Minn. Patients: Three women with relapsing-remitting MS. Interventions: Body temperature measurement, symptom diary, and oral aspirin. Main Outcome Measures: Body temperature, Modified Fatigue Impact Scale, and evaluation of neurologic symptoms and signs. Results: Morning oral body temperature did not differ during symptomatic vs asymptomatic portions of the luteal phase (P= .55). Aspirin (650 mg twice daily) prevented symptoms but did not significantly alter the luteal phase body temperature. Conclusions: Aspirin prophylaxis may prevent luteal phase-associated MS pseudoexacerbations. However, the observed relationship between the luteal menstrual phase and MS symptom worsening is not fully explained by thermoregulation, which implicates other hormonal or immunologic mechanisms.",
author = "Wingerchuk, {Dean Marko} and Moses Rodriguez",
year = "2006",
doi = "10.1001/archneur.63.7.1005",
language = "English (US)",
volume = "63",
pages = "1005--1008",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "7",

}

TY - JOUR

T1 - Premenstrual multiple sclerosis pseudoexacerbations

T2 - Role of body temperature and prevention with aspirin

AU - Wingerchuk, Dean Marko

AU - Rodriguez, Moses

PY - 2006

Y1 - 2006

N2 - Background: Many women with multiple sclerosis (MS) experience transient neurologic symptom worsening and fatigue in conjunction with the menstrual cycle. Aspirin reduces MS fatigue in some patients. Objective: To describe 3 women with MS who experienced stereotypic, temperature-independent neurologic symptoms and diurnal fatigue in the mid-to-late luteal phase of the menstrual cycle. Aspirin treatment prevented the symptoms. Design and Setting: Case series at the Mayo Clinic outpatient MS clinics, Scottsdale, Ariz, and Rochester, Minn. Patients: Three women with relapsing-remitting MS. Interventions: Body temperature measurement, symptom diary, and oral aspirin. Main Outcome Measures: Body temperature, Modified Fatigue Impact Scale, and evaluation of neurologic symptoms and signs. Results: Morning oral body temperature did not differ during symptomatic vs asymptomatic portions of the luteal phase (P= .55). Aspirin (650 mg twice daily) prevented symptoms but did not significantly alter the luteal phase body temperature. Conclusions: Aspirin prophylaxis may prevent luteal phase-associated MS pseudoexacerbations. However, the observed relationship between the luteal menstrual phase and MS symptom worsening is not fully explained by thermoregulation, which implicates other hormonal or immunologic mechanisms.

AB - Background: Many women with multiple sclerosis (MS) experience transient neurologic symptom worsening and fatigue in conjunction with the menstrual cycle. Aspirin reduces MS fatigue in some patients. Objective: To describe 3 women with MS who experienced stereotypic, temperature-independent neurologic symptoms and diurnal fatigue in the mid-to-late luteal phase of the menstrual cycle. Aspirin treatment prevented the symptoms. Design and Setting: Case series at the Mayo Clinic outpatient MS clinics, Scottsdale, Ariz, and Rochester, Minn. Patients: Three women with relapsing-remitting MS. Interventions: Body temperature measurement, symptom diary, and oral aspirin. Main Outcome Measures: Body temperature, Modified Fatigue Impact Scale, and evaluation of neurologic symptoms and signs. Results: Morning oral body temperature did not differ during symptomatic vs asymptomatic portions of the luteal phase (P= .55). Aspirin (650 mg twice daily) prevented symptoms but did not significantly alter the luteal phase body temperature. Conclusions: Aspirin prophylaxis may prevent luteal phase-associated MS pseudoexacerbations. However, the observed relationship between the luteal menstrual phase and MS symptom worsening is not fully explained by thermoregulation, which implicates other hormonal or immunologic mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=33745813928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745813928&partnerID=8YFLogxK

U2 - 10.1001/archneur.63.7.1005

DO - 10.1001/archneur.63.7.1005

M3 - Article

C2 - 16831971

AN - SCOPUS:33745813928

VL - 63

SP - 1005

EP - 1008

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 7

ER -